RESEARCH · GHK-CU · AGEING BIOLOGY
GHK-Cu and Ageing Research: Plasma Decline Claims, C. elegans Lifespan, Senescence, Fibrosis and Aged-Mouse Studies
PurixLab’s GHK-Cu 50mg is a research vial of the copper complex of glycyl-L-histidyl-L-lysine. Our earlier articles cover gene expression and matrix remodelling, antioxidant, lung and colitis models and the nervous system. This article follows one thread through all of them: ageing. GHK is often described as an “anti-ageing” peptide, and this article looks at what that claim rests on. It covers the claim that plasma levels decline with age, the first lifespan study, senescence and fibrosis models, and work in aged mice. These are findings from published research; the vial is supplied for laboratory research use only, and nothing here is treatment guidance or a claim about any PurixLab product.
An origin story about old and young tissue
GHK was first reported in 1973 by Pickart and Thaler as a factor in human serum that prolonged survival of normal liver cells and stimulated growth in hepatoma cells [1,2]. Later reviews by Pickart describe the discovery as an activity in human albumin that caused old human liver tissue to synthesise proteins like younger tissue [2]. The 1973 paper has no abstract in PubMed, so the age framing comes to us mainly through these later reviews. From the start, the “ageing” interest was linked to cell culture and protein synthesis, not to lifespan.
Does plasma GHK fall with age?
A widely repeated figure is that GHK in human plasma averages about 200 ng/mL at age 20 and falls to about 80 ng/mL by age 60. It appears in a 2020 review in Aging Pathobiology and Therapeutics [3]. We could not trace these numbers to a primary population study in the abstracts we reviewed. Independent measurements are scarce. One study used reversed-phase HPLC to measure plasma GHK in 9 patients with chronic obstructive pulmonary disease and 11 age-paired healthy subjects: levels were 70.27 ± 38.87 ng/mL in the patients and 133.0 ± 54.54 ng/mL in the controls, and in the patients lower GHK was associated with smaller pectoralis muscle area [4]. That is a disease comparison, not an age series, and the samples are small. A properly sized, mass-spectrometry-based study of GHK across age groups would be needed to settle the claim.
The first lifespan study: C. elegans
Lifespan is the most direct test of an anti-ageing claim, and for GHK-Cu it has been examined only in nematodes. In a 2026 Biogerontology paper, GHK-Cu significantly extended the lifespan of Caenorhabditis elegans. Treated worms also had better resistance to oxidative and heat stress, better motility, pharyngeal pumping and defecation rhythm, and less lipofuscin and lipid accumulation [5]. Mechanistically, the authors reported higher mitochondrial membrane potential and less age-related mitochondrial fragmentation, a shift toward fusion via drp-1 and fzo-1, more ATP, and activation of the DAF-16 and SKN-1 stress-response pathways [5]. The abstract does not give the size of the lifespan extension. Worm lifespan assays are sensitive to temperature, bacterial food and copper content, and a copper complex could act partly through the metal.
Senescent and stressed fibroblasts
Cellular senescence is a central mechanism in ageing biology. Here the direct evidence is thin. In a study of hydrogen peroxide-induced premature senescence in human skin fibroblasts, GHK was one of 5 cosmetic peptides screened. Its optimal concentration was chosen for its effect on hydroxyproline content, a collagen marker [6]. However, the mixture that performed best in the senescence experiments did not contain GHK [6]. A 2024 commentary proposes that GHK may reverse senescence and induce apoptosis in myofibroblasts, improve migration of aged lung fibroblasts and act through integrin-β1 signalling [7]. It is a commentary, not a primary study.
The integrin link has primary data behind it. In lung tissue from smokers with COPD, Campbell and colleagues profiled 8 regions from each of 8 lungs and found 127 genes associated with regional emphysema severity. Tissue-repair genes, including the TGF-β pathway, actin organisation and integrin signalling, decreased as destruction increased [8]. Connectivity Map analysis identified GHK as a compound that could reverse this signature. In human fibroblasts, GHK organised the actin cytoskeleton and raised integrin β1, and either GHK or TGF-β restored collagen gel contraction by fibroblasts from COPD lungs [8]. COPD is a disease of older smokers, but this is a disease model, not an ageing model as such.
Fibrosis: a TGF-β paradox
Age-related fibrosis is one of the ageing questions researchers raise for GHK [7]. Yet the TGF-β data point in two directions. In the COPD work, GHK reproduced TGF-β-induced gene-expression patterns [8]. In normal human dermal fibroblasts, by contrast, GHK, GHK-Cu and free copper ions all decreased TGF-β1 secretion stimulated by IGF-2 [9]. In bleomycin lung fibrosis in mice, GHK reduced collagen deposition and reversed increases in TGF-β1 and Smad2/3 phosphorylation [10], and GHK-Cu had similar effects with added Nrf2 and NF-κB changes [11]. A molecule that mimics TGF-β in one context and suppresses it in another may be restoring balance, as proponents argue. It may also be responding to differences in cell type, copper status and assay. Neither bleomycin study used aged animals.
Aged mice
Most aged-animal work comes from one research group with overlapping authors. In mice aged 20 months, two months of intranasal GHK-Cu improved spatial learning and navigation and lowered neuroinflammatory and axonal damage markers [12]. In ageing mice deprived of sleep, GHK prevented the learning impairment and the rise in hippocampal MCP-1 and nitrotyrosine [13]. A 2026 preprint compared short intraperitoneal and longer intranasal delivery in mice aged 20-21 months. Both routes improved escape learning, but they produced opposite hippocampal transcriptional programs: intranasal delivery suppressed oxidative phosphorylation and MYC targets, while intraperitoneal delivery activated them along with DNA repair [14]. The authors conclude that route and exposure duration determine the molecular response. Two of these three reports are preprints, and none has an independent replication.
Ageing skin: mostly combinations
Human skin data on GHK-Cu and ageing mostly involve mixtures. A 2026 study found that Copper Tripeptide-1 increased elastin expression in dermal fibroblasts and tested it together with ethyl ferulate and cedrol on UV-damaged human skin biopsies [15]. A single-patient case report used a device-assisted solution containing copper-GHK plus four other actives [16]. Neither isolates GHK-Cu. Older controlled studies on aged skin are summarised in a 2008 review [17], but those trials are not individually indexed in a way we could verify here.
What remains open
- The age-decline figure needs primary data. The 200-to-80 ng/mL trajectory is cited in reviews; independent age-stratified measurements are lacking [3,4].
- Lifespan in mammals is untested. The only lifespan data are from C. elegans [5].
- Senescence markers. Direct tests of GHK-Cu on senescent cells, using markers such as p16, p21 and senescence-associated secretory factors, are largely missing; the 2026 preprint reported a p21 decrease only in females given intraperitoneal treatment [14].
- One research network. Much of the aged-mouse work and the fibrosis commentary come from one group [12,13,14,7].
- Copper versus peptide. Free copper also lowered TGF-β1 secretion in fibroblasts [9], so controls with copper alone are needed to attribute effects to the peptide.
A 2026 gerontology review places GHK-Cu among investigational peptides with promising preclinical and limited clinical evidence but no long-term safety data or systematic validation [18]. On the evidence above, that is a fair summary.
GHK-Cu 50mg at PurixLab
GHK-Cu 50mg: a labelled lyophilized research vial with 50mg per vial, C$49 per vial (CAD, before tax), supplied for laboratory research only. It is not a cosmetic; our separate Copper Facial Mask is the finished cosmetic product. Batch documentation is available on request. Product page: purixlab.com/product/ghk-cu-50mg/.
PurixLab ships within Canada only, from stock held in Toronto. Standard shipping is C$15, and shipping is free when the product subtotal is C$200 or more after discounts. Orders outside the GTA ship by Canada Post Xpresspost. Prices are in CAD and taxes are calculated from your shipping address at checkout.
In Toronto and the GTA, our own team delivers orders the same day or the next day. There is no fixed GTA delivery fee: after you place your order, we email you to confirm the delivery time and any delivery charge, and then you pay. There is no storefront or local pickup.
Payment is by Interac e-Transfer (instructions are shown at checkout) or by cryptocurrency through Plisio (Bitcoin, Ethereum, USDT and more): choose Plisio at checkout and you are sent to a secure Plisio payment page after placing the order. Current offers and any pack pricing are shown on the product page and in your cart; offers do not stack.
For laboratory research use only. Not for human or veterinary use, not for consumption, injection or application to skin, and purchasers must be 18 or older. The studies summarised above describe specific materials in published research; they are not claims about any PurixLab product.
Questions or batch documentation requests: [email protected] · Shipping & Delivery · Toronto & GTA delivery · PurixLab FAQ
References
- Pickart L, Thaler MM. Tripeptide in human serum which prolongs survival of normal liver cells and stimulates growth in neoplastic liver. Nat New Biol. 1973;243(124):85-7. PubMed 4349963
- Pickart L, Vasquez-Soltero JM, Margolina A. The human tripeptide GHK-Cu in prevention of oxidative stress and degenerative conditions of aging: implications for cognitive health. Oxid Med Cell Longev. 2012;2012:324832. PubMed 22666519 · PMC3359723 · doi:10.1155/2012/324832
- Dou Y, Lee A, Zhu L, et al. The potential of GHK as an anti-aging peptide. Aging Pathobiol Ther. 2020;2(1):58-61. PubMed 35083444 · PMC8789089 · doi:10.31491/apt.2020.03.014
- Deng M, Zhang Q, Yan L, et al. Glycyl-l-histidyl-l-lysine-Cu2+ rescues cigarette smoking-induced skeletal muscle dysfunction via a sirtuin 1-dependent pathway. J Cachexia Sarcopenia Muscle. 2023;14(3):1365-1380. PubMed 36905132 · PMC10235902 · doi:10.1002/jcsm.13213
- Wen H, Zhao K, Luo X, et al. The GHK-Cu delays aging in Caenorhabditis elegans via coordinated regulation of mitochondrial function and activation of DAF-16/SKN-1 pathways. Biogerontology. 2026;27(3):100. PubMed 42084774 · doi:10.1007/s10522-026-10444-x
- Wu Y, Cao K, Zhang W, et al. Protective and Anti-Aging Effects of 5 Cosmeceutical Peptide Mixtures on Hydrogen Peroxide-Induced Premature Senescence in Human Skin Fibroblasts. Skin Pharmacol Physiol. 2021;34(4):194-202. PubMed 33849044 · doi:10.1159/000514496
- He Q, Mazzola J, Ladiges W. The naturally occurring peptide GHK reverses age-related fibrosis by modulating myofibroblast function. Aging Pathobiol Ther. 2024;6(4):186-190. PubMed 40823151 · PMC12352503 · doi:10.31491/apt.2024.12.158
- Campbell JD, McDonough JE, Zeskind JE, et al. A gene expression signature of emphysema-related lung destruction and its reversal by the tripeptide GHK. Genome Med. 2012;4(8):67. PubMed 22937864 · PMC4064320 · doi:10.1186/gm367
- Gruchlik A, Chodurek E, Dzierzewicz Z. Effect of GLY-HIS-LYS and its copper complex on TGF-β secretion in normal human dermal fibroblasts. Acta Pol Pharm. 2014;71(6):954-8. PubMed 25745767
- Zhou XM, Wang GL, Wang XB, et al. GHK Peptide Inhibits Bleomycin-Induced Pulmonary Fibrosis in Mice by Suppressing TGFβ1/Smad-Mediated Epithelial-to-Mesenchymal Transition. Front Pharmacol. 2017;8:904. PubMed 29311918 · PMC5733019 · doi:10.3389/fphar.2017.00904
- Ma WH, Li M, Ma HF, et al. Protective effects of GHK-Cu in bleomycin-induced pulmonary fibrosis via anti-oxidative stress and anti-inflammation pathways. Life Sci. 2020;241:117139. PubMed 31809714 · doi:10.1016/j.lfs.2019.117139
- Tucker M, Keely A, Park JY, et al. Intranasal GHK peptide enhances resilience to cognitive decline in aging mice. bioRxiv. 2023:2023.11.16.567423. PubMed 38014118 · PMC10680828 · doi:10.1101/2023.11.16.567423
- Rosenfeld M, Nickel K, Ladiges W. GHK peptide prevents sleep-deprived learning impairment in aging mice. Aging Pathobiol Ther. 2023;5(1):33-35. PubMed 37035833 · PMC10081520 · doi:10.31491/apt.2023.03.109
- Mazzola J, Rosenfeld M, Tucker M, et al. Middle-aged mice treated with GHK-Cu peptide administered intraperitoneally or intranasally show behavioral rescue but divergent hippocampal aging programs. Res Sq. 2026:rs.3.rs-9520102. PubMed 42245779 · PMC13232416 · doi:10.21203/rs.3.rs-9520102/v1
- Ye S, Kang S, Jeong ET, et al. Multi-Target Restoration of Dermal Elastic Fibers Through Elastin Upregulation, Elastase Suppression, and Scaffold Reinforcement. Curr Issues Mol Biol. 2026;48(5):431. PubMed 42193036 · PMC13204052 · doi:10.3390/cimb48050431
- Byun SY, Chae JB, Na JI, et al. Significant improvement in crow's feet after treatment with Jet-M and a mixed solution of copper-GHK, oligo-hyaluronic acid, rhodiolar extract, tranexamic acid, and β-glucan (GHR formulation). J Cosmet Laser Ther. 2016;18(5):293-5. PubMed 27064823 · doi:10.3109/14764172.2016.1157367
- Pickart L. The human tri-peptide GHK and tissue remodeling. J Biomater Sci Polym Ed. 2008;19(8):969-88. PubMed 18644225 · doi:10.1163/156856208784909435
- Mavrych V, Shypilova I, Bolgova O. Therapeutic peptides in gerontology: mechanisms and applications for healthy aging. Front Aging. 2026;7:1790247. PubMed 42021992 · PMC13095733 · doi:10.3389/fragi.2026.1790247